Currently out of the existing stock ratings of Vik Chopra, 23 are a HOLD (52.27%), 21 are a BUY (47.73%).

Vik Chopra

Work Performance Price Targets & Ratings Chart

Analyst Vik Chopra, currently employed at WELLS FARGO, carries an average stock price target met ratio of 53.24% that have a potential upside of 12.12% achieved within 78 days.

Vik Chopra’s has documented 88 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SOLV, Solventum Corp. at 15-Sep-2025.

Wall Street Analyst Vik Chopra

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for IART (INTEGRA LIFESCIENCES HOLDINGS) at 5/6/2024. The price target of $25 was fulfilled within 1 day with a profit of $1.86 (8.04%) receiving and performance score of 80.38.

Average potential price target upside

of $11.4 (8.04%) on MASI (MASIMO).
of $6.4 (10.21%) on GMED (GLOBUS MEDICAL).
of $6.04 (81.83%) on NPCE (NEUROPACE).

ENOV Enovis Corp GMED Globus Medical MASI Masimo NUVA NuVasive HSIC Henry Schein CNMD CONMED IART Integra LifeSciences Holdings NPCE Neuropace NVST Envista Holdings Corp XRAY Dentsply Sirona SOLV Solventum Corp. ALGN Align Technology

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mike Matson (NEEDHAM)